AI Article Synopsis

  • This study investigates the impact of free haem and iron on vascular health in patients with blood disorders like β-thalassaemia, hereditary spherocytosis, and sickle cell disease, showing that these substances can cause inflammation and vascular issues.
  • Researchers found elevated levels of haem and iron in patients, leading to increased oxidative stress and markers of inflammation compared to healthy individuals.
  • The findings suggest that targeting free haem and iron with specific therapies could help manage vascular dysfunction and inflammation in these blood disorders.

Article Abstract

Increasing evidence suggests that free haem and iron exert vasculo-toxic and pro-inflammatory effects by activating endothelial and immune cells. In the present retrospective study, we compared serum samples from transfusion-dependent patients with β-thalassaemia major and intermedia, hereditary spherocytosis and sickle cell disease (SCD). Haemolysis, transfusions and ineffective erythropoiesis contribute to haem and iron overload in haemolytic patients. In all cohorts we observed increased systemic haem and iron levels associated with scavenger depletion and toxic 'free' species formation. Endothelial dysfunction, oxidative stress and inflammation markers were significantly increased compared to healthy donors. In multivariable logistic regression analysis, oxidative stress markers remained significantly associated with both haem- and iron-related parameters, while soluble vascular cell adhesion molecule 1 (sVCAM-1), soluble endothelial selectin (sE-selectin) and tumour necrosis factor α (TNFα) showed the strongest association with haem-related parameters and soluble intercellular adhesion molecule 1 (sICAM-1), sVCAM-1, interleukin 6 (IL-6) and vascular endothelial growth factor (VEGF) with iron-related parameters. While hereditary spherocytosis was associated with the highest IL-6 and TNFα levels, β-thalassaemia major showed limited inflammation compared to SCD. The sVCAM1 increase was significantly lower in patients with SCD receiving exchange compared to simple transfusions. The present results support the involvement of free haem/iron species in the pathogenesis of vascular dysfunction and sterile inflammation in haemolytic diseases, irrespective of the underlying haemolytic mechanism, and highlight the potential therapeutic benefit of iron/haem scavenging therapies in these conditions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252605PMC
http://dx.doi.org/10.1111/bjh.17361DOI Listing

Publication Analysis

Top Keywords

haem iron
16
vasculo-toxic pro-inflammatory
8
transfusion-dependent patients
8
β-thalassaemia major
8
hereditary spherocytosis
8
oxidative stress
8
iron-related parameters
8
parameters soluble
8
adhesion molecule
8
pro-inflammatory action
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!